MB
Morrison Briggs Other
US US · SEC (Form 4)
Discover the full record of transactions filed by Morrison Briggs. Insider active across 2 companies, notably Syndax Pharmaceuticals Inc. In total, 9 reports have been published. Total volume traded: €94k. The latest transaction was filed on 14 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 9 total
€239,357 16,188 shares @ €14.7861 0.031% mcap 34.6% of flow
Common Stock
SEC:0001209191-22-024674:0 · 14 Apr 2022
€458,732 70,545 shares @ €6.5027 0.026% mcap 22.0% of flow
Common Stock
SEC:0001562180-22-003383:0 · 1 Apr 2022
€94,500 6,000 shares @ €15.7499 0.0053% mcap 4.5% of flow
Common Stock
SEC:0001562180-22-003223:0 · 1 Apr 2022
€226,067 16,188 shares @ €13.9651 0.030% mcap 100.0% of flow
Common Stock
SEC:0000899243-22-002557 · 14 Jan 2022
€226,067 16,188 shares @ €13.9651 0.030% mcap 32.7% of flow
Common Stock
SEC:0000899243-22-002557:0 · 14 Jan 2022
€338,094 35,156 shares @ €9.617 0.019% mcap 44.0% of flow
Common Stock
SEC:0001562180-21-007810 · 17 Dec 2021
€338,094 35,156 shares @ €9.617 0.019% mcap 16.2% of flow
Common Stock
SEC:0001562180-21-007810:0 · 17 Dec 2021
€429,902 70,262 shares @ €6.1186 0.024% mcap 56.0% of flow
Common Stock
SEC:0001562180-21-006038 · 17 Sept 2021
€429,902 70,262 shares @ €6.1186 0.024% mcap 20.6% of flow
Common Stock
SEC:0001562180-21-006038:0 · 17 Sept 2021
About Morrison Briggs Morrison Briggs is a director at Syndax Pharmaceuticals Inc and an insider at multiple companies, including Arvinas, INC.